These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 19995837

  • 21. Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis.
    Amato MP, Portaccio E, Goretti B, Zipoli V, Battaglini M, Bartolozzi ML, Stromillo ML, Guidi L, Siracusa G, Sorbi S, Federico A, De Stefano N.
    Arch Neurol; 2007 Aug; 64(8):1157-61. PubMed ID: 17698706
    [Abstract] [Full Text] [Related]

  • 22. Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia.
    Smith EE, Egorova S, Blacker D, Killiany RJ, Muzikansky A, Dickerson BC, Tanzi RE, Albert MS, Greenberg SM, Guttmann CR.
    Arch Neurol; 2008 Jan; 65(1):94-100. PubMed ID: 18195145
    [Abstract] [Full Text] [Related]

  • 23. Cognitive impairment in newly diagnosed multiple sclerosis patients: a 4-year follow-up study.
    Jønsson A, Andresen J, Storr L, Tscherning T, Soelberg Sørensen P, Ravnborg M.
    J Neurol Sci; 2006 Jun 15; 245(1-2):77-85. PubMed ID: 16647089
    [Abstract] [Full Text] [Related]

  • 24. Angiotensin converting enzyme (ACE) inhibitors modulate the rate of progression of amnestic mild cognitive impairment.
    Rozzini L, Chilovi BV, Bertoletti E, Conti M, Del Rio I, Trabucchi M, Padovani A.
    Int J Geriatr Psychiatry; 2006 Jun 15; 21(6):550-5. PubMed ID: 16642542
    [Abstract] [Full Text] [Related]

  • 25. Cognitive and psychosocial features of childhood and juvenile MS.
    Amato MP, Goretti B, Ghezzi A, Lori S, Zipoli V, Portaccio E, Moiola L, Falautano M, De Caro MF, Lopez M, Patti F, Vecchio R, Pozzilli C, Bianchi V, Roscio M, Comi G, Trojano M, Multiple Sclerosis Study Group of the Italian Neurological Society.
    Neurology; 2008 May 13; 70(20):1891-7. PubMed ID: 18474844
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment.
    Tabert MH, Manly JJ, Liu X, Pelton GH, Rosenblum S, Jacobs M, Zamora D, Goodkind M, Bell K, Stern Y, Devanand DP.
    Arch Gen Psychiatry; 2006 Aug 13; 63(8):916-24. PubMed ID: 16894068
    [Abstract] [Full Text] [Related]

  • 29. Increased peripheral blood CD5+ B cells predict earlier conversion to MS in high-risk clinically isolated syndromes.
    Villar LM, Espiño M, Roldán E, Marín N, Costa-Frossard L, Muriel A, Alvarez-Cermeño JC.
    Mult Scler; 2011 Jun 13; 17(6):690-4. PubMed ID: 21436320
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Ventricular size, cognitive function and depression in patients with multiple sclerosis.
    Clark CM, James G, Li D, Oger J, Paty D, Klonoff H.
    Can J Neurol Sci; 1992 Aug 13; 19(3):352-6. PubMed ID: 1393845
    [Abstract] [Full Text] [Related]

  • 34. Disconnection as a mechanism for cognitive dysfunction in multiple sclerosis.
    Dineen RA, Vilisaar J, Hlinka J, Bradshaw CM, Morgan PS, Constantinescu CS, Auer DP.
    Brain; 2009 Jan 13; 132(Pt 1):239-49. PubMed ID: 18953055
    [Abstract] [Full Text] [Related]

  • 35. Correlation of global N-acetyl aspartate with cognitive impairment in multiple sclerosis.
    Mathiesen HK, Jonsson A, Tscherning T, Hanson LG, Andresen J, Blinkenberg M, Paulson OB, Sorensen PS.
    Arch Neurol; 2006 Apr 13; 63(4):533-6. PubMed ID: 16606765
    [Abstract] [Full Text] [Related]

  • 36. Cognitive impairment and structural brain damage in benign multiple sclerosis.
    Rovaris M, Riccitelli G, Judica E, Possa F, Caputo D, Ghezzi A, Bertolotto A, Capra R, Falautano M, Mattioli F, Martinelli V, Comi G, Filippi M.
    Neurology; 2008 Nov 04; 71(19):1521-6. PubMed ID: 18815387
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Defining high, medium and low impact prognostic factors for developing multiple sclerosis.
    Tintore M, Rovira À, Río J, Otero-Romero S, Arrambide G, Tur C, Comabella M, Nos C, Arévalo MJ, Negrotto L, Galán I, Vidal-Jordana A, Castilló J, Palavra F, Simon E, Mitjana R, Auger C, Sastre-Garriga J, Montalban X.
    Brain; 2015 Jul 04; 138(Pt 7):1863-74. PubMed ID: 25902415
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.